Literature DB >> 34559973

Inhibition of microRNA-297 alleviates THLE-2 cell injury induced by hypoxia/reoxygenation by inhibiting NLRP3 inflammasome activation via sirtuin 3.

Yuan Yue1, Zhilin Du2, Jie Tao2, Lei Shi2.   

Abstract

It has been acknowledged that microRNAs (miRNAs/miRs) assume a critical role in hypoxia/reoxygenation (H/R) - induced hepatocyte injury. Therefore, cell experiments were performed in this study to investigate the mechanism of miR-297 in H/R-induced hepatocyte injury with the involvement of sirtuin 3 (SIRT3) and NOD-like receptor pyrin domain containing 3 (NLRP3). Initially, transformed human liver epithelial-2 (THLE-2) cells were utilized for H/R challenge. After miR-297 antagomir and NLRP3 adenovirus vector delivery, THLE-2 cell proliferation and apoptosis were measured by MTT, EdU, and TUNEL assays, respectively. Enzyme-linked immunosorbent assay was conducted to evaluate the levels of apoptosis-related indicators (Bax and Bcl-2) and inflammation-related indicators (interleukin 6 (IL-6) and IL-10), Western blot analysis to detect NLRP3, and cleaved caspase-1 expression. The binding relation between miR-297 and SIRT3 was examined using dual-luciferase assay. The results showed that miR-297 antagomir repressed the apoptosis and inflammation induced by H/R treatment in THLE-2 cells. Mechanistically, miR-297 antagomir diminished the extent of IκBα and nuclear factor-kappa B (NF-κB) phosphorylation and NLRP3 activation in H/R-induced THLE-2 cells by targeting SIRT3. Furthermore, NLRP3 overexpression normalized the promoting effects of miR-297 antagomir on proliferation and its inhibitory effects on apoptosis and inflammation in H/R-induced THLE-2 cells. In summary, our results elucidated that miR-297 antagomir repressed H/R-induced THLE-2 cell injury via SIRT3 promotion and NLRP3 inactivation.

Entities:  

Keywords:  NLRP3; NOD-like receptor pyrin domain containing 3; antagomir du microRNA-297; hepatic ischemia-reperfusion injury; hypoxia/reoxygenation; hypoxie/reoxygenation; lésions d’ischémie-reperfusion hépatiques; microRNA-297 antagomir; sirtuin 3; sirtuine 3

Mesh:

Substances:

Year:  2021        PMID: 34559973     DOI: 10.1139/cjpp-2021-0287

Source DB:  PubMed          Journal:  Can J Physiol Pharmacol        ISSN: 0008-4212            Impact factor:   2.273


  5 in total

1.  Human Amnion-Derived Mesenchymal Stromal/Stem Cells Pre-Conditioning Inhibits Inflammation and Apoptosis of Immune and Parenchymal Cells in an In Vitro Model of Liver Ischemia/Reperfusion.

Authors:  Giovanni Zito; Vitale Miceli; Claudia Carcione; Rosalia Busà; Matteo Bulati; Alessia Gallo; Gioacchin Iannolo; Duilio Pagano; Pier Giulio Conaldi
Journal:  Cells       Date:  2022-02-17       Impact factor: 6.600

Review 2.  Sirtuin deficiency and the adverse effects of fructose and uric acid synthesis.

Authors:  Bernardo Rodriguez-Iturbe; Richard J Johnson; Miguel A Lanaspa; Takahiko Nakagawa; Fernando E Garcia-Arroyo; Laura G Sánchez-Lozada
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2022-03-10       Impact factor: 3.619

Review 3.  MicroRNAs: Novel Targets in Hepatic Ischemia-Reperfusion Injury.

Authors:  Holly Ingram; Murat Dogan; James D Eason; Cem Kuscu; Canan Kuscu
Journal:  Biomedicines       Date:  2022-03-29

4.  The Effect of PGC-1alpha-SIRT3 Pathway Activation on Pseudomonas aeruginosa Infection.

Authors:  Nicholas M Maurice; Brahmchetna Bedi; Zhihong Yuan; Kuo-Chuan Lin; Joanna B Goldberg; C Michael Hart; Kristina L Bailey; Ruxana T Sadikot
Journal:  Pathogens       Date:  2022-01-19

Review 5.  From cerebral ischemia towards myocardial, renal, and hepatic ischemia: Exosomal miRNAs as a general concept of intercellular communication in ischemia-reperfusion injury.

Authors:  Wenqiang Xin; Yafei Qin; Ping Lei; Jianning Zhang; Xinyu Yang; Zengguang Wang
Journal:  Mol Ther Nucleic Acids       Date:  2022-08-24       Impact factor: 10.183

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.